Revolution Medicines Inc.



Market open

 --Real time quotes

Jun 6, 2023, 12:27 p.m.





+0.91 +3.51%


Volume 320,662

Real time quotes


Previous close

$ 25.82

$ 26.73


+0.91 +3.51%

Day low

Day high




52 week low

52 week high




Annual Financials for Revolution Medicines Inc.

Fiscal year is January-December. All values USD millions. 20182019202020212022 5-year trend
Sales/Revenue 20.17M50.04M42.98M29.39M35.38M
Cost of Goods Sold (COGS) incl. D&A 1.76M--7.33M9.66M
COGS excluding D&A -----
Depreciation & Amortization Expense 1.76M3.34M6.55M7.33M9.66M
Depreciation 1.57M2.27M5.48M6.26M8.59M
Amortization of Intangibles 198,0001.07M1.07M1.07M1.07M
Gross Income 18.4M--22.06M25.72M
20182019202020212022 5-year trend
SG&A Expense 58.33M100.22M147.14M210.07M284M
Research & Development 51.08M91.16M128.57M182.8M248.03M
Other SG&A 7.25M9.06M18.56M27.27M35.97M
Other Operating Expense -----
Unusual Expense 2.52M----
EBIT after Unusual Expense (42.45M)----
Non Operating Income/Expense -(597,000)---
Non-Operating Interest Income 777,0002.19M2.24M929,0009.15M
Equity in Affiliates (Pretax) -----
Interest Expense 116,000106,00071,00012,000-
Gross Interest Expense 116,000106,00071,00012,000-
Interest Capitalized -----
Pretax Income (41.79M)(52.04M)(108.53M)(187.09M)(249.13M)
Income Tax -(4.37M)(371,000)-(420,000)
Income Tax - Current Domestic -(4.37M)(371,000)--
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (41.79M)(47.66M)(108.16M)(187.09M)(248.71M)
Minority Interest Expense -----
Net Income (41.79M)(47.66M)(108.16M)(187.09M)(248.71M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (41.79M)(47.66M)(108.16M)(187.09M)(248.71M)
Preferred Dividends 7.03M14.24M2.22M--
Net Income Available to Common (48.82M)(61.9M)(110.38M)(187.09M)(248.71M)
EPS (Basic) (0.83)(1.05)(1.66)(2.57)(3.08)
Basic Shares Outstanding 59M59M66.6M72.81M80.63M
EPS (Diluted) (0.83)(1.05)(1.66)(2.57)(3.08)
Diluted Shares Outstanding 59M59M66.6M72.81M80.63M
EBITDA (38.17M)(50.18M)(104.15M)(180.68M)(248.62M)
Link to MarketWatch's Slice.